Antimicrobial susceptibility of Mycoplasma bovis isolates from Bosnia and Herzegovina

被引:0
|
作者
Rifatbegovic, Maid [1 ]
Bacic, Azra [2 ]
Pasic, Semso [1 ]
Maksimovic, Zinka [1 ]
机构
[1] Univ Sarajevo, Vet Fac, Dept Microbiol & Infect Dis, Zmaja Bosne 90, Sarajevo 71000, Bosnia & Herceg
[2] Inst Biomed Diagnost & Res GENOM, Slavka Gavrancica 17c, Travnik 72270, Bosnia & Herceg
关键词
Antimicrobial resistance; Minimum inhibitory concentration; Mycoplasma bovis; CATTLE; INHIBITION; DIAGNOSIS; PROFILES; CALVES;
D O I
10.14943/jjvr.69.1.43
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The minimum inhibitory concentrations (MICs) of enrofloxacin, ciprofloxacin, norfloxacin, gentamicin, spectinomycin, oxytetracycline, tylosin, florfenicol and tiamulin were determined against 24 Mycoplasma bovis isolates from cattle in Bosnia and Herzegovina using the microbroth dilution test. The lowest MIC values (<= 0.03 mu g/ml) were obtained for tiamulin, gentamicin and oxytetracycline. Spectinomycin and tylosin had the highest MIC values (>= 128 mu g/ml). Tiamulin had the lowest MIC50 value (<0.03 mu g/ml) and MIC90 value (0.5 mu g/ml). Among the fluoroquinolones, enrofloxacin had the lowest MIC50 value (0.25 mu g/ml) and MIC90 value (1 mu g/ml), followed by ciprofloxacin (MIC50 of 0.5 mu g/ml; MIC90 of 2 mu g/ml). The highest MIC50 value (4 mu g/ml) was found for norfloxacin, oxytetracycline and tylosin, while spectinomycin and tylosin yielded the highest MIC90 values (>128 mu g/ml).
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [1] Susceptibility of Mycoplasma bovis field isolates to antimicrobial agents
    Siugzdaite, J.
    Gabinaitiene, A.
    Kerziene, S.
    VETERINARNI MEDICINA, 2012, 57 (11) : 575 - 582
  • [2] Changes in antimicrobial susceptibility of Mycoplasma bovis isolates from Great Britain
    Ayling, R. D.
    Rosales, R. S.
    Barden, G.
    Gosney, F. L.
    VETERINARY RECORD, 2014, 175 (19) : 486
  • [3] Isolation of Mycoplasma bovis from the respiratory tract of cattle in Bosnia and Herzegovina
    Rifatbegovic, M.
    Assuncao, P.
    Poveda, J. B.
    Pasic, S.
    VETERINARY RECORD, 2007, 160 (14) : 484 - 485
  • [4] Antimicrobial Susceptibility of Mycoplasma bovis Isolates from Veal, Dairy and Beef Herds
    Bokma, Jade
    Gille, Linde
    De Bleecker, Koen
    Callens, Jozefien
    Haesebrouck, Freddy
    Pardon, Bart
    Boyen, Filip
    ANTIBIOTICS-BASEL, 2020, 9 (12): : 1 - 12
  • [5] Antimicrobial susceptibility of Mycoplasma bovis isolates from veal calves and dairy cattle in the Netherlands
    Heuvelink, Annet
    Reugebrink, Constance
    Mars, Jet
    VETERINARY MICROBIOLOGY, 2016, 189 : 1 - 7
  • [6] In vitro antimicrobial susceptibility of Mycoplasma bovis clinical isolates recovered from bison (Bison bison)
    Suleman, Muhammad
    Prysliak, Tracy
    Windeyer, Claire
    Perez-Casal, Jose
    CANADIAN JOURNAL OF MICROBIOLOGY, 2016, 62 (03) : 272 - 278
  • [7] Antimicrobial susceptibility and molecular characterization of macrolide resistance of Mycoplasma bovis isolates from multiple provinces in China
    Kong, Ling-Cong
    Gao, Duo
    Jai, Bo-Yan
    Wang, Zi
    Gao, Yun-Hang
    Pei, Zhi-Hua
    Liu, Shu-Ming
    Xin, Jiu-Qing
    Ma, Hong-Xia
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (02): : 293 - 296
  • [8] Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents
    Fagre, Anna C.
    Pugazhenthi, Uma
    Cheleuitte-Nieves, Christopher
    Crim, Marcus J.
    Henderson, Kenneth S.
    Fong, Derek L.
    Leszczynski, Jori K.
    Schurr, Michael J.
    Daniels, Joshua B.
    Manuel, Christopher A.
    COMPARATIVE MEDICINE, 2021, 71 (03) : 210 - 214
  • [9] Protein and Antigenic Profile among Mycoplasma bovis Field Strains Isolated in Bosnia and Herzegovina
    Rifatbegovic, Maid
    Assuncao, Patricia
    Pasic, Semso
    de la Fe, Christian
    Poveda, Jose B.
    ACTA VETERINARIA BRNO, 2009, 78 (01) : 151 - U17
  • [10] Antibiotic susceptibility of Campylobacter jejuni and Campylobacter coli human isolates from Bosnia and Herzegovina
    Uzunovic-Kamberovic, S
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 1049 - 1051